Jodi Lynch

Head of Department of Medical Oncology

St George's Hospital

Australia

Research Interests

Explore related searches

Professors in Australia Professors in Medical Imaging Medical Imaging professors in Australia

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jodi Lynch is the Head of the Department of Medical Oncology at St George Hospital in Australia. Her research primarily focuses on cancer treatment outcomes, telehealth experiences during the COVID-19 pandemic, and novel predictive methods in breast cancer survivorship. Recent publications include studies on triple negative breast cancer and the implications of telehealth for cancer patients, contributing significantly to advancements in oncological care and treatment strategies.

Articles (8)

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Kate Webber

Adjunct Senior Lecturer

MONASH UNIVERSITY

AUSTRALIA

View details

Ewan Millar

Honorary Visiting Professorship

University of Sydney

AUSTRALIA

View details

Renee Whan

Head of Biomedical Imaging Facility

University of New South Wales

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jodi Lynch

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Experiences and Satisfaction With Telehealth During the COVID-19 Pandemic: The Perspectives of Patients With Cancer in Australia

Survival prediction in triple negative breast cancer using multiple instance learning of histopathological images

Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study

Multiplexed immunofluorescence identifies high stromal CD68<sup>+</sup>PD-L1<sup>+</sup> macrophages as a predictor of improved survival in triple negative breast cancer

Disseminated intravascular coagulation complicating diagnosis of ROS1‐mutant non‐small cell lung cancer: A case report and literature review

CDK4/6 inhibitor plus endocrine therapy for hormone receptor‐positive, HER2‐negative metastatic breast cancer: The new standard of care

Tumour Stroma Ratio Assessment Using Digital Image Analysis Predicts Survival in Triple Negative and Luminal Breast Cancer

Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio

Collaborators (3)

Kate Webber

Ewan Millar

Renee Whan

Make your next move.